Did they really just add more placebo patients or just more patients overall to the trial? I can't see how just adding more placebo patients to the trial would be ethically or scientifically OK.
Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events, page-21
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.3¢ |
Change
-0.003(0.27%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 92.5¢ | 89.5¢ | $2.739M | 3.029M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 116812 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 71877 | 39 |
View Market Depth
| Last trade - 14.49pm 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |